Enzo Biochem Balance Sheet Health
Financial Health criteria checks 6/6
Enzo Biochem has a total shareholder equity of $56.1M and total debt of $265.0K, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are $85.8M and $29.7M respectively.
Key information
0.5%
Debt to equity ratio
US$265.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$52.37m |
| Equity | US$56.11m |
| Total liabilities | US$29.65m |
| Total assets | US$85.76m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0IHV's short term assets ($70.0M) exceed its short term liabilities ($24.8M).
Long Term Liabilities: 0IHV's short term assets ($70.0M) exceed its long term liabilities ($4.9M).
Debt to Equity History and Analysis
Debt Level: 0IHV has more cash than its total debt.
Reducing Debt: 0IHV's debt to equity ratio has reduced from 5% to 0.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0IHV has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0IHV has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 31% each year.